# Development of Anti-Infective Drug Products for the Pediatric Population :  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/development-of-anti-infective-drug-products-for-the-pediatric-population-guidance-for-industry/93fc101d-c235-4c5e-8254-82649ec6d7fb

> FDA guidance document: Development of Anti-Infective Drug Products for the Pediatric Population :  Guidance for Industry. Issue date: December 09, 2021. Get complete insights and analysis.

---

## Details

- Title: Development of Anti-Infective Drug Products for the Pediatric Population :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-12-09
- Last Changed: 2024-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1518">FDA-2020-D-1518</a>

## Related Documents

- [Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/limited-population-pathway-for-antibacterial-and-antifungal-drugs-guidance-for-industry/f01d33af-ed26-4eb5-961a-03e00c90f2c7)
- [Pediatric HIV Infection: Drug Development for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-hiv-infection-drug-development-for-treatment/2fd110e1-e45d-44ba-8efb-87a9ba7b8d23)
- [Rare Diseases: Considerations for the Development of Drugs and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/rare-diseases-considerations-for-the-development-of-drugs-and-biological-products/de40ca53-dec2-46b7-8321-a251e09d47bb)